Skip to Content

DB03 (Letrozole 2.5 mg)

Pill with imprint DB03 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by APP Pharmaceuticals, LLC.

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DB03

Letrozole

Imprint:
DB03
Strength:
2.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
APP Pharmaceuticals, LLC
Inactive Ingredients:
silicon dioxide colloidal
hypromelloses
lactose monohydrate
magnesium stearate
corn starch
microcrystalline cellulose
polyethylene glycol
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide